Pfizer (NYSE: PFE) is America's largest pharmaceutical company, but it's about to become a lot smaller. A narrow focus could lead to explosive growth, but it won't make cash flows any more predictable.
Will Pfizer give investors the earnings growth they desire, or should they prepare for trouble ahead? Here's what you need to know about the factors that will determine the pharma giant's direction over the next five years.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,